10x Insights
Loading account…
Companies / Financials / Stablecoin Development Corp
SDEV

Stablecoin Development Corp

FinancialsFinance Services
Ticker SDEVWEST PALM BEACH, FLFiscal year ends DecemberBook value per share $0.69Diluted shares 184.8M

NovaBay Pharmaceuticals, Inc. (NYSE American: NYSM) operates as a digital asset treasury company following a comprehensive strategic realignment of its business operations. The company's website is located at www.novabay.com. From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
—
0.00%
$-630.78M
−8632.9% year over year
Last 12 mo $-125.19M
99.84%
−5499.4 percentage points
Last 12 mo -98.39%
Cash & financing
$-8.43M
−62.6% year over year
Last 12 mo $-11.88M
$-8.43M
−62.5% year over year
Last 12 mo $-11.88M
-0.00
Was -4.38× a year earlier
Last 12 mo 0.00
—
Last 12 mo 184.8M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Stablecoin Development Corp does

In the company’s own words

NovaBay Pharmaceuticals, Inc. (NYSE American: NYSM) operates as a digital asset treasury company following a comprehensive strategic realignment of its business operations. The company's website is located at www.novabay.com.

Historically, NovaBay focused on the development and commercialization of scientifically-created and clinically-proven eyecare, wound care, and skin care products. However, the company has undergone significant transformation through a series of completed divestitures. In January 2025, NovaBay sold its Avenova eyecare product line and related assets to PRN Physician Recommended Nutriceuticals, LLC, which represented the sale of substantially all of its then revenue-generating operating assets. Also in January 2025, the company divested its wound care product trademarks, including NeutroPhase and PhaseOne, to Phase One Health LLC. Subsequently, NovaBay exited its remaining China NeutroPhase product line in October 2025 as part of its strategic shift.

Following these divestitures, NovaBay adopted a new capital allocation strategy focused on acquiring and holding digital assets that provide exposure to economic participation within open digital financial networks. The company's primary strategic objective centers on acquiring SKY, the protocol token of the decentralized Sky network, a blockchain-based software protocol deployed on the Ethereum blockchain that is developed around the USDS stablecoin. As of January 2026, NovaBay held approximately 943.6 million SKY tokens following a private placement transaction that raised approximately $137.4 million in gross proceeds through a combination of cash, stablecoins, and digital assets.

The company maintains custody of its digital assets through U.S.-based service providers including Fireblocks and Kraken, which provide wallet infrastructure, key management technology, and institutional digital asset custody services. NovaBay's strategy contemplates holding digital assets for extended periods as long-term positions, periodically monetizing portions of holdings for corporate purposes, and evaluating opportunities to generate liquidity through assets held by the company.

As of December 31, 2025, NovaBay employed four individuals on a consolidated basis. The company maintains its principal executive office in Emeryville, California, where it leases approximately 7,675 square feet of office space with a lease expiration date of July 31, 2027.

Company details
Sector
Financials
Industry
Finance Services
Headquarters
WEST PALM BEACH, FL
Fiscal year end
December
CIK
1389545
SIC
6199

Financial performance, year by year

Fiscal 2013–2025 · USD
$-695.68M$-500.98M$-306.27M$-111.57M$83.13M2013201420152016201720182019202020212022202320242025Last 12 moLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Stablecoin Development Corp — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

6
funds hold it
0 of 35
superinvestors hold it
$0.69M
held by funds, at market
1.2%
of shares held by funds

Largest fund holders · Stablecoin Development Corp’s weight in each

VANGUARD EXTENDED MARKET INDEX FUND
VXF · VANGUARD INDEX FUNDS
0.00%of fund net assets
Fidelity Extended Market Index Fund
FSMAX · Fidelity Concord Street Trust
0.00%of fund net assets
Fidelity Total Market Index Fund
FSKAX · Fidelity Concord Street Trust
0.00%of fund net assets
0.00%of fund net assets
Fidelity Series Total Market Index Fund
FCFMX · Fidelity Concord Street Trust
0.00%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Stablecoin Development Corp and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Stablecoin Development Corp's earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Stablecoin Development Corp's last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.